Epilepsy is not inherently progressive for most people who have it. The majority of epilepsy cases can be controlled with medication, and many childhood epilepsy syndromes resolve on their own. However, certain types of epilepsy are clearly progressive, and even in non-progressive forms, uncontrolled seizures can cause cumulative changes to the brain over time.
Most Epilepsy Stays Stable or Resolves
The International League Against Epilepsy (ILAE) now uses the term “self-limited” to describe several epilepsy syndromes, particularly those beginning in childhood, that are likely to resolve spontaneously. These replaced the older label “benign,” but the core idea is the same: many people with epilepsy reach a point where seizures stop, sometimes permanently.
For adults with epilepsy that responds to medication, the condition typically remains stable for years or decades. The seizures are suppressed, and the underlying brain activity doesn’t necessarily worsen. That said, current anti-seizure medications are purely symptomatic. They control seizures but do not fix the underlying cause or prevent the condition from persisting. Most people require continued treatment for years to decades because no available drug actually modifies the disease process itself.
When Epilepsy Is Genuinely Progressive
A small but important group of epilepsy syndromes are definitively progressive, meaning both seizures and neurological function worsen over time regardless of treatment. The clearest examples are the progressive myoclonus epilepsies (PMEs), a family of genetic conditions characterized by worsening seizures, involuntary muscle jerks, and steady neurological decline.
Lafora disease is one of the most severe. It typically begins between ages 8 and 19, often around 14 to 16, in previously healthy teenagers. Seizures become increasingly frequent and resistant to medication. Cognitive decline begins at or near seizure onset, followed by difficulty speaking, loss of coordination, and eventually dementia. Myoclonus (involuntary jerking) gradually becomes near-constant. Most affected individuals lose the ability to walk before age 21 and reach a vegetative state within about ten years of onset. Other PMEs include Unverricht-Lundborg disease and MERRF (a mitochondrial disorder), each with its own trajectory but sharing the pattern of worsening over time.
Rasmussen’s encephalitis is another progressive form, though it follows a different pattern. It causes drug-resistant focal seizures, progressive weakness on one side of the body, and cognitive decline, all driven by inflammation that slowly destroys one hemisphere of the brain. Untreated, children typically develop significant weakness, vision loss, and cognitive problems within a year of seizure onset. The disease eventually burns out into a residual stage with severe fixed deficits and ongoing difficult-to-treat seizures.
Dravet syndrome, a genetic epilepsy beginning in infancy, also carries elevated risks. The rate of sudden unexpected death in epilepsy (SUDEP) in Dravet syndrome is 9.32 per 1,000 person-years, roughly eight times the rate in the general epilepsy population.
How Uncontrolled Seizures Change the Brain
Even in epilepsy types that aren’t classified as progressive, poorly controlled seizures can cause cumulative brain damage. The primary mechanism involves excitatory neurotransmitters like glutamate. During a seizure, neurons fire excessively, flooding surrounding cells with glutamate. This overstimulation, called excitotoxicity, causes acute swelling and degeneration of neurons. Sustained seizure activity lasting longer than one hour consistently results in cellular damage, particularly in the hippocampus, the brain’s memory center.
Longitudinal brain imaging studies confirm this. In temporal lobe epilepsy, the hippocampus progressively shrinks over time, particularly in patients with existing hippocampal damage. Researchers have measured ongoing tissue loss in a key hippocampal region at a rate of roughly 0.03 cubic millimeters per year on both sides of the brain. The amygdala and surrounding cortical areas also show volume reduction with prolonged, uncontrolled seizures.
Status epilepticus, a seizure lasting longer than five minutes or repeated seizures without recovery between them, poses especially high risk. Prolonged episodes can cause significant volume reduction in the hippocampus, amygdala, and surrounding brain regions. Longer duration is consistently linked to worse outcomes, including permanent motor and cognitive deficits, though the severity depends heavily on the underlying cause.
Cognitive Effects Over Time
Cognitive problems are common in people with epilepsy, and they can accumulate. The most frequently affected areas are memory, attention, executive function (planning, organizing, switching between tasks), and processing speed. People with temporal lobe epilepsy tend to have the most pronounced memory problems, which makes sense given that seizures in this region directly damage the hippocampus, a structure essential for forming and retrieving memories.
Frontal lobe epilepsy tends to impair attention and complex behaviors like planning, initiating tasks, and working memory. Across epilepsy types, people with epilepsy perform worse than healthy individuals on tests of verbal fluency, psychomotor speed, and visual-spatial abilities. Older adults with epilepsy show the steepest declines across all cognitive areas.
Even between seizures, abnormal electrical activity in the brain (called interictal discharges) appears to take a toll. These subclinical spikes accumulate over time and are associated with impaired learning and memory. Animal studies have shown that this kind of background epileptic activity slows down the processes involved in short-term memory formation, even when no visible seizure is occurring.
Taking multiple anti-seizure medications also contributes. A higher number of medications is associated with poorer language and visual-spatial abilities, creating a frustrating trade-off between seizure control and cognitive side effects.
Why Early Seizure Control Matters
Because seizures themselves can drive brain changes, achieving seizure control early appears to protect long-term brain health. This is especially clear in children with drug-resistant epilepsy who undergo surgery. In one controlled study, children who had epilepsy surgery showed improved IQ and developmental scores over two years, along with gains in verbal memory and working memory. Children in the control group, who were surgical candidates but hadn’t yet had the procedure, showed no such improvement over the same period. The developmental trajectories diverged: only the surgical group moved upward.
This doesn’t mean surgery is right for everyone, but it illustrates a broader principle. Stopping seizures, by whatever means, changes the brain’s trajectory for the better. The longer seizures go uncontrolled, the more cumulative damage they cause, and the harder it becomes to recover lost ground.
SUDEP and Mortality Risk
The most serious long-term risk of uncontrolled epilepsy is sudden unexpected death in epilepsy, or SUDEP. It is the leading cause of epilepsy-related death in adults, occurring at a rate of about 1.2 per 1,000 person-years in the general epilepsy population. In drug-resistant epilepsy, that rate jumps to roughly 6.7 per 1,000. A 40-year study following 245 children diagnosed with epilepsy found a threefold increase in mortality compared to the general population, with 30% of deaths attributed to SUDEP.
Socioeconomic factors also play a role. Between 2010 and 2015, the gap in SUDEP rates between the lowest and highest income groups widened, even as overall SUDEP rates declined. This likely reflects disparities in access to consistent medical care and seizure management. The core takeaway is that seizure control is the single most important factor in reducing SUDEP risk. In Dravet syndrome, for example, one targeted medication was shown to reduce mortality from 9.32 to 1.7 per 1,000 person-years.